Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Columbia and HCA divests as HealthSouth buys ASC

This article was originally published in Clinica

Executive Summary

Columbia/HCA has cancelled hospital building and plans to sell most of the recently-acquired Value Health business. At the same time, HealthSouth, which has shown interest in acquiring some or all of the beleaguered healthcare group, will pay $180 million in cash and debt assumption for a chain of 29 surgery centres. Columbia recently paid $1.1 billion for Value Health and now intends to sell its pharmacy benefits management company which represents around 80% of Value Health's $1.8 billion turnover. Columbia will also shed the managed care company specialising in behavioural therapy and the information technology-based disease management division.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT085864

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel